节点文献

荔枝核皂苷对高脂血症-脂肪肝大鼠的降血糖调血脂作用

Effects of saponin of Litchi on decreasing blood glucose and con trolling blood lipid in hyperlipemia-fatty liver rats fed by ligh-sugar-fat

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 郭洁文廖惠芳潘竞锵叶碧波简小兵魏丹蕾戴莲仪

【Author】 GUO Jie-Wen, LIAO Hui-Fang1, PAN Jing-Qiang2, YE Bi-Bo3, JIAN Xiao-Bi ng4, WEI Dan-Lei4, DAI Lian-Yi4 Department of Agent, 4 Departemnt of Endocrine, Guangzhou Hospital of Tradi tional Chinese Medicine, Guangzhou 510130, Guangdong, China; 1 Departemnt of Pharacology, Guangzhou University of Traditional Chinese Medicine, Guangzhou 51 0405, Guangdong, China; 2 Departement of Pharacology, Guangzhou Institute of Traditional Chinese Medicine and Materia Medica, Guangzhou 510130, Guangdong, China; 3 Institute of Drug Guangdong Provincial Institute of Materia Medica, Guangzhou 510180, Guangdong, China[ [FL(K2]

【机构】 广州市中医医院药剂科广州中医药大学药理研究室广州市中医中药研究所药理研究室广东省药物研究所植化室广州市中医医院内分泌科广州市中医医院内分泌科 广州510130广东广东广州510405广州510130广州510180广州510130

【摘要】 目的 :研究荔枝核皂苷和罗格列酮对高脂血症 脂肪肝大鼠血糖血脂的影响。方法 :采用高脂血症 脂肪肝大鼠模型 ,观察荔枝核皂苷和罗格列酮、格列齐特对病鼠空腹血糖 (FBG)、口服葡萄糖耐量试验 (OGTT)后 2h血糖 (2hBG)以及给药后 2h空腹血清血糖 (FSG)、总胆固醇 (TC)、三酰甘油 (TG)、高密度脂蛋白 胆固醇 (HDL C)、低密度脂蛋白 胆固醇 (LDL C)、血清尿素氮 (BUN)、肌酐 (Cr)、丙氨酸氨基转移酶 (ALT)、天冬氨酸氨基转移酶 (AST)及镜检肝组织病理学等指标的影响。结果 :荔枝核皂苷和罗格列酮能显著改善高脂血症 脂肪肝致胰岛素抵抗 (IR)模型大鼠的IGT ,降低OGTT后 2hBG和FSG(P <0 .0 5 ) ;并能显著降低病鼠TC、TG、LDL C含量(P <0 .0 5~ 0 .0 1) ,显著提高HDL C含量 (P <0 .0 5 ) ;降低病鼠ALT、AST活性和BUN、Cr含量 (P<0 .0 5 ) ,改善肝细胞脂肪变性 (P <0 .0 1)。结论 :荔枝核皂苷和罗格列酮能提高胰岛素的敏感性 ,调整高脂血症 脂肪肝所致的糖脂代谢障碍 ,并具有改善病鼠肝肾功能的作用。

【Abstract】 AIM: To investigate the effects of sapo ni n of Litchi seed(SL) and roglitazone on decreasing blood gluco se, Lipid and amelioration hepatic, nephritic function in hyperl ipemia-fatty liver rats fed by high-sugar-fat. METHODS: The animal model with hyperlipemia-fatty liver was prepared in rats by feeding on high caloric diet (abounded of sugar and fat) for 10 weeks. After 6 weeks treatm ent, the effects of SL, roglitazone and gliclazide (intragastrointestinally admi nistered, qd for 4 weeks) on fasting blood glucose(FBG),2-hour blood glucose (2hBG)after oral glucose tolerance test(OGTT),serum contents of fasting gluc ose(FSG), total cholesterol(TC) , triacylglycerol (TG), low-density lipoprote in cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), blood u rea nitrogen (BUN), creatine (Cr) and serum activities of alanine aminotransfera se (ALT), and aspartate aminotransferase (AST) and hepatic histopathology were o bserved by microscope. RESULTS:After administration of SL and roglitazone, the serum concentrations of fasting blood glucose (FSG) and 2-hour blood glucose (2hBG) after oral glucose tolerance test (OGTT) significantly dec reased (P< 0.05); the impaired glucose tolerance (IGT) improv ed; the level of TG, TC, and LDL-C decreased (P< 0.05); the content of HDL-C augmented (P< 0.05); the concentrations of BUN and Cr, activities of ALT and AST decreased (P< 0.05); an d the fatty degeneration of hepatocytes improved (P< 0.01). CONCLUSION: SL and roglitazone can control hyperinsulinemia, en hance insulin sensitivity, reduce level of blood glucose, regulate components an d contents of blood lipid, and improve both of function in liver and kidney.

【基金】 广东省中医药局滚动资助项目 (№ 3 0 2 0 0 2 ) ;广州市医药卫生科技项目 (№ 2 0 0 410 7)
  • 【文献出处】 中国临床药理学与治疗学 ,Chinese Journal of Clinical Pharmacology and Therapeutics , 编辑部邮箱 ,2004年12期
  • 【分类号】R285
  • 【被引频次】34
  • 【下载频次】518
节点文献中: 

本文链接的文献网络图示:

本文的引文网络